EPL
- Market cap
- ₹ 7,080 Cr.
- P/E
- 17.3x
- P/B
- 2.53x
- 52-week range
- 176.4 – 274.03
- ROE
- 16%
- ROCE
- 18%
- Dividend yield
- 1.1%
- Debt / equity
- 0.34
- Sector
- Industrial Products
- Industry
- Packaging
- Listed on
- NSE, BSE
About
EPL Limited is an India-based packaging company. The Company is engaged in the manufacturing of plastic packaging material in the form of multilayer collapsible tubes, corrugated boxes and laminates used primarily for packaging of consumer products in the beauty and cosmetics, health and pharmaceuticals, food, home and oral care categories. Its geographical segments include AMESA - Africa, Middle East and South Asia (with operations in Egypt and India); EAP - East Asia Pacific (with operations in China and the Philippines); AMERICAS (with operations in the United States of America, Mexico, Brazil and Colombia), and EUROPE (with operations in the United Kingdom, Poland, Russia and Germany). The Company’s product segments, including laminates, laminated tubes, extruded tubes, caps and closures, and dispensing systems. The Company produces specialty laminates in its facilities in China and India. It also produces tamper-evident closures for the protection of products.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Packaging: 96 companies →EPL against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)17.3 against a typical 18: cheaper than most peers (1st = cheapest).45th of 95
- Sales growth+25.3% against a typical +22.9% from a year earlier.33rd of 74
- Profit growth0% against a typical +25.3% from a year earlier.46th of 68
- Share price, 3 months−5.2% against a typical −3.6%.49th of 87
- Size₹ 7,079.9 Cr. market value against a typical ₹ 116.3 Cr. (1st = largest).1st of 88
Latest announcements
Exchange filings and their impact on the company.
- EPL raised Rs 60 crore via 3-month commercial paper at 8.05% yield for routine funding.
EPL Limited issued and allotted Rs 60 crore of commercial papers on October 27, 2026, comprising 1200 units of Rs 5 lakh each. The papers carry a discount rate of 7.89% and yield of 8.05% and mature on January 25, 2027. The company said the allotment is not material and is being listed on NSE, indicating routine short-term funding with no meaningful impact on the business.
- Exchanges clear EPL-Indovida merger plan with no objections; NCLT process can proceed.
EPL said it received observation letters with no adverse observations from BSE and NSE on October 19, 2026 for its proposed amalgamation of Indovida India Private Limited with EPL. The scheme was approved by EPL's board on March 29, 2026 and filed with the exchanges on April 22, 2026. The no-objection clears the way for the next regulatory and NCLT steps, with no financial terms disclosed.
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA+ by 2 agencies- All agencies agree and none has raised a warning.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE AA+ (Rating Watch with Developing Implications) / CARE A1+ | — | 6 Oct 2026 |
| India Ratings | IND AA+ | Rating Watch with Developing Implication | 10 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 6 Oct 2026 | Reaffirmed | CARE AA+ / CARE A1+ (Rating Watch with Developing Implications) → CARE AA+ (Rating Watch with Developing Implications) / CARE A1+ | — | CARE | ₹ 766.23 Cr. | |
| 10 Sep 2026 | Reaffirmed | IND AA+ | — | India Ratings | ₹ 200 Cr. | |
| 29 Apr 2026 | Reaffirmed | CARE AA+ / CARE A1+ (Rating Watch with Developing Implications) | — | CARE | ₹ 694.95 Cr. | |
| 8 Apr 2026 | Reaffirmed | CARE AA+ / CARE A1+ → CARE AA+ / CARE A1+ (Rating Watch with Developing Implications) | — | CARE | ₹ 544.95 Cr. | |
| 27 Nov 2025 | Reaffirmed | IND AA+ | — | India Ratings | ₹ 200 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 11 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 14 May 2026 | Financial Results | To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31, 2026 |
| 13 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 11 Nov 2025 | Fund Raising | To consider adoption of the Employee Stock Option Scheme - 2025' |
| 5 Aug 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 8 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the quarter and financial year ended March 31, 2025 and final dividend, if any, on the Equity Shares of the Company, for the financial year ended March 31, 2025. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,002 | 975 | 1,029 | 1,007 | 1,086 | 1,014 | 1,105 | 1,108 | 1,206 | 1,149 | 1,300 | 1,388 |
| Expenses | 821 | 792 | 838 | 822 | 868 | 813 | 877 | 881 | 954 | 919 | 1,044 | 1,127 |
| Operating Profit | 181 | 183 | 191 | 186 | 219 | 202 | 228 | 227 | 252 | 230 | 256 | 261 |
| OPM % | 18% | 19% | 19% | 18% | 20% | 20% | 21% | 20% | 21% | 20% | 20% | 19% |
| Other Income | 11 | 24 | −44 | 6 | 14 | 13 | 11 | 8 | 12 | 2 | −7 | 6 |
| Interest | 31 | 29 | 32 | 29 | 29 | 27 | 28 | 28 | 28 | 29 | 29 | 29 |
| Depreciation | 84 | 84 | 85 | 84 | 85 | 86 | 88 | 90 | 94 | 97 | 104 | 109 |
| Profit before tax | 78 | 94 | 30 | 80 | 118 | 100 | 123 | 117 | 141 | 107 | 116 | 129 |
| Tax % | 33% | 7% | 50% | 17% | 25% | 6% | 6% | 14% | 25% | 22% | 11% | 22% |
| Net Profit | 52 | 87 | 15 | 66 | 88 | 94 | 116 | 101 | 106 | 83 | 103 | 101 |
| EPS in Rs | 1.59 | 2.71 | 0.7 | 2.02 | 2.73 | 2.93 | 3.58 | 3.13 | 3.26 | 2.55 | 3.21 | 3.08 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 8%
- 5 Years
- 9%
- 3 Years
- 9%
- TTM
- 17%
- 10 Years
- 9%
- 5 Years
- 10%
- 3 Years
- 22%
- TTM
- 3%
- 10 Years
- 9%
- 5 Years
- 2%
- 3 Years
- 7%
- TTM
- —
- 10 Years
- 14%
- 5 Years
- 14%
- 3 Years
- 15%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| EPL | ₹ 213.11 | ₹ 7,080 Cr. | 17.3x | 2.5x | 16% | — |
| AGI Greenpac | ₹ 685.25 | ₹ 4,436 Cr. | 12.7x | 1.9x | 15.6% | 13.2% |
| Uflex | ₹ 555.20 | ₹ 4,015 Cr. | 9.5x | 0.4x | 4.1% | 2.1% |
| TCPL Packaging | ₹ 3,842.10 | ₹ 3,489 Cr. | 27.3x | 4.1x | 14.4% | 5.4% |
| Mold-Tek Packaging | ₹ 290.00 | ₹ 966 Cr. | 32x | 3.4x | 11% | 8.2% |
| Nilkamal | ₹ 1,623.00 | ₹ 2,403 Cr. | 17.6x | 1.4x | 7.5% | 3.1% |
Management
- Hemant Bakshi
- Global Chief Executive Officer, Managing Director, Additional Executive Director
- Deepak Goyal
- Chief Financial Officer
- Mauro Catopodis
- President - Americas Region
- Hariharan K. Nair
- President - Creativity and Innovation
- Shrihari K. Rao
- President - AMESA Region
- Nevaneeth Selvan
- President - Europe Region
- Rajiv Verma
- President - Technology and Printing
- Kelvin Wang
- President - EAP Region
Prices are delayed and for information only. Nothing on this page is investment advice.